Early Patient Access to Medicines: Health Technology Assessment Bodies Need to Catch Up with New Marketing Authorization Methods

Publisher： Karger

E-ISSN： 1662-8063|19|3|187-191

ISSN： 1662-4246

Source： Public Health Genomics, Vol.19, Iss.3, 2016-06, pp. : 187-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized Medicine

By  

Public Health Genomics, Vol. 18, Iss. 5, 2015-0 ,pp. : 249-259

Karger

Access to resources Recommend Favorite

Enabling Equal Access to Molecular Diagnostics: What Are the Implications for Policy and Health Technology Assessment?

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 144-152

Karger

Access to resources Recommend Favorite

Patient and Citizen Participation in Health: The Need for Improved Ethical Support

By Williamson Laura  

American Journal of Bioethics, Vol. 14, Iss. 6, 2014-06 ,pp. : 4-16

Routledge Ltd

Access to resources Recommend Favorite

A Conceptual Framework of Mapping Access to Health Care across EU Countries: The Patient Access Initiative

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 153-159

Karger

Access to resources Recommend Favorite

The Contribution of Health Technology Assessment, Health Needs Assessment, and Health Impact Assessment to the Assessment and Translation of Technologies in the Field of Public Health Genomics

By  

Public Health Genomics, Vol. 14, Iss. 1, 2010-10 ,pp. : 43-52

Karger

Access to resources Recommend Favorite